These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 9682040)

  • 21. Multiple sclerosis and reproductive risks in women.
    Argyriou AA; Makris N
    Reprod Sci; 2008 Oct; 15(8):755-64. PubMed ID: 19017813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G; Napoletano R; Esposito A
    Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
    Neuteboom RF; Hintzen RQ
    Neurology; 2011 Apr; 76(17):1532; author reply 1532-3. PubMed ID: 21519008
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
    Pastò L; Portaccio E; Ghezzi A; Hakiki B; Giannini M; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi GL; Solaro C; Totaro R; Tola MR; Di Tommaso V; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP;
    BMC Neurol; 2012 Dec; 12():165. PubMed ID: 23276328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population.
    De Las Heras V; De Andrés C; Téllez N; Tintoré M;
    Mult Scler; 2007 Sep; 13(8):981-4. PubMed ID: 17623725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis and pregnancy.
    Tsui A; Lee MA
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):435-9. PubMed ID: 22011954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis.
    Haas J; Hommes OR
    Mult Scler; 2007 Aug; 13(7):900-8. PubMed ID: 17881400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of postpartum abuse in women with a history of abuse during pregnancy.
    Stewart DE
    CMAJ; 1994 Dec; 151(11):1601-4. PubMed ID: 7954159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.
    Lavie C; Rollot F; Durand-Dubief F; Marignier R; Ionescu I; Casey R; Moreau T; Tourniaire P; Hutchinson M; D'Hooghe MB; Laplaud DA; Clavelou P; De Sèze J; Debouverie M; Brassat D; Pelletier J; Lebrun-Frenay C; Le Page E; Castelnovo G; Berger E; Hautecoeur P; Heinzlef O; Durelli L; Clerico M; Trojano M; Patti F; Vukusic S;
    Mult Scler; 2019 Apr; 25(4):591-600. PubMed ID: 31081475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy.
    Hellwig K; Tokic M; Thiel S; Esters N; Spicher C; Timmesfeld N; Ciplea AI; Gold R; Langer-Gould A
    JAMA Netw Open; 2022 Jan; 5(1):e2144750. PubMed ID: 35072719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
    Kappos L; Radue EW; O'Connor P; Polman C; Hohlfeld R; Calabresi P; Selmaj K; Agoropoulou C; Leyk M; Zhang-Auberson L; Burtin P;
    N Engl J Med; 2010 Feb; 362(5):387-401. PubMed ID: 20089952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of pregnancy in women with moderate or severe renal insufficiency.
    Jones DC; Hayslett JP
    N Engl J Med; 1996 Jul; 335(4):226-32. PubMed ID: 8657238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study.
    Salemi G; Callari G; Gammino M; Battaglieri F; Cammarata E; Cuccia G; D'Amelio M; Lupo I; Ragonese P; Savettieri G
    Acta Neurol Scand; 2004 Jul; 110(1):23-6. PubMed ID: 15180803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapartum analgesia and its association with post-partum back pain and headache in nulliparous women.
    Orlikowski CE; Dickinson JE; Paech MJ; McDonald SJ; Nathan E
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):395-401. PubMed ID: 16953853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effect of neutralizing antibodies to interferon beta that persist long after cessation of therapy for multiple sclerosis.
    van der Voort LF; Gilli F; Bertolotto A; Knol DL; Uitdehaag BM; Polman CH; Killestein J
    Arch Neurol; 2010 Apr; 67(4):402-7. PubMed ID: 20142519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pregnancy and multiple sclerosis].
    Moreau T; Brunot S; Couvreur G; Fromont A
    Presse Med; 2010 Mar; 39(3):389-94. PubMed ID: 20116203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Mikaeloff Y; Edan G; Clanet M; Dubois B; Debouverie M; Brochet B; Lebrun-Frenay C; Pelletier J; Moreau T; Lubetzki C; Vermersch P; Roullet E; Magy L; Tardieu M; Suissa S; Confavreux C;
    N Engl J Med; 2007 Jun; 356(25):2603-13. PubMed ID: 17582070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.